According to a new market report published by Persistence Market Research “Global Market Study on Next-Generation Antibody Therapeutics: Biosimilar Antibody Products to Witness Highest Growth by 2022”, the global next-generation antibody therapeutics market is project to be valued at US$ 2,250.0 Mn by the end of 2015 and is expected to expand at a CAGR of 13.0% from 2015 to 2022, to account for US$ 6,761.1 Mn by 2022.
FACTS AT A GLANCE
Companies: ImmunoGen, Inc., Bayer AG, Biogen, Xencor, Inc., F. Hoffmann-La Roche Ltd., Kyowa Hakko Kirin Co., Ltd., Dyax Corp., Amgen, Inc., and Seattle Genetics, Inc.
Planning Forward? Access Sample of Next Generation Antibody Therapeutics Market Report @ https://www.persistencemarketresearch.com/samples/3713
Coverage: All major geographies and key segments
Segments: By Technology (Antibody-Drug Conjugates (ADCs),Bispecific Antibodies (BsAbs) ,Fc Engineered Antibodies,Antibody Fragments and Antibody-like Proteins,Biosimilar Antibody Products); By Therapeutic Application (Oncology,Autoimmune/Inflammatory Diseases)
Geographies: North America; Europe; Asia; Rest of the World.
Get A Customized Scope To Match Your Need Ask An Expert – sales@persistencemarketresearch.com
ABSTRACT-
Persistence Market Research recently published a report on the global next-generation antibody therapeutics market. This report analyzes the market condition over a six-year forecast period, 2016-2022. It is an extensive study of all the factors that are associated with the market and are likely to impact market growth over the aforementioned period. The study demonstrates market dynamics and trends across regions that are expected to influence the current status and future prospects of the global next-generation antibody therapeutics market.
How About Re-Inventing The Methodical Wheel In The Next Generation Antibody Therapeutics Market? Switch Over To The “Methodology” Tab! https://www.persistencemarketresearch.com/methodology/3713
The primary objective of the report is to offer information on market drivers, restraints, trends, opportunities, and value chain analysis. Moreover, it also updates on recent and upcoming developments in the global next-generation antibody therapeutics market. The report begins with an overview of the global next-generation antibody therapeutics market which includes market description, taxonomy, yearly growth rates, revenues, and forecast period. Thereafter, the report elaborates key trends, opportunities, drivers and restraints from the supply and demand perspectives.
The next section of the report segments the market on the basis of technology and application, and presents the forecast in terms of value for the next six years. Segmentation provides valuable insights into the largest and fastest growing segments of the market, drivers, opportunities, revenue shares, and growth prospects. Regional analysis discusses the historic, current, and estimated condition of each of the four key regional markets. In the final section, the market report offers a competitive landscape, including all the key companies operating in the global next-generation antibody therapeutics market.
Planning To Introduce An Offbeat Product/Technology In The Next Generation Antibody Therapeutics Market? Go To “Purchase Now” To Have Our Next Generation Antibody Therapeutics Market Report! https://www.persistencemarketresearch.com/checkout/3713
About us: – Persistence market research
Contact Us:
Address – 305 Broadway, 7th Floor, New York City, NY 10007 United States
U.S. Ph. – +1-646-568-7751
USA-Canada Toll-free – +1 800-961-0353
Sales – sales@persistencemarketresearch.com
Website – https://www.persistencemarketresearch.com